NFE2L2 and COVID-19: There are no previous reports associating this polymorphism with COVID-19; however, NFE2L2 polymorphisms may modulate the expression of the transcription factor or affect its ability to translocate into the nucleus and bind to the ARE site in target gene promoters [22].